Synergistic effect of Hypoxic Conditioning and Cell-Tethering Colloidal Gels enhanced Productivity of MSC Paracrine Factors and Accelerated Vessel Regeneration
- PMID: 39380372
- PMCID: PMC11757084
- DOI: 10.1002/adma.202408488
Synergistic effect of Hypoxic Conditioning and Cell-Tethering Colloidal Gels enhanced Productivity of MSC Paracrine Factors and Accelerated Vessel Regeneration
Abstract
Microporous hydrogels have been widely used for delivering therapeutic cells. However, several critical issues, such as the lack of control over the harsh environment they are subjected to under pathological conditions and rapid egression of cells from the hydrogels, have produced limited therapeutic outcomes. To address these critical challenges, cell-tethering and hypoxic conditioning colloidal hydrogels containing mesenchymal stem cells (MSCs) are introduced to increase the productivity of paracrine factors locally and in a long-term manner. Cell-tethering colloidal hydrogels that are composed of tyramine-conjugated gelatin prevent cells from egressing through on-cell oxidative phenolic crosslinks while providing mechanical stimulation and interconnected microporous networks to allow for host-implant interactions. Oxygenating microparticles encapsulated in tyramine-conjugated colloidal microgels continuously generated oxygen for 2 weeks with rapid diffusion, resulting in maintaining a mild hypoxic condition while MSCs consumed oxygen under severe hypoxia. Synergistically, local retention of MSCs within the mild hypoxic-conditioned and mechanically robust colloidal hydrogels significantly increased the secretion of various angiogenic cytokines and chemokines. The oxygenating colloidal hydrogels induced anti-inflammatory responses, reduced cellular apoptosis, and promoted numerous large blood vessels in vivo. Finally, mice injected with the MSC-tethered oxygenating colloidal hydrogels significantly improved blood flow restoration and muscle regeneration in a hindlimb ischemia (HLI) model.
Keywords: colloidal gel; hMSC; hypoxic conditioning; ischemic disease; mechanical stimulation; oxygenating microparticles; paracrine effect; vessel regeneration.
© 2024 Wiley‐VCH GmbH.
Conflict of interest statement
Competing interests
The authors declare no conflict of interest.
References
-
- Comerota AJ, Link A, Douville J, Burchardt ER, J Vasc Surg 2010, 52, 723; - PubMed
- Powell RJ, J Vasc Surg 2012.
MeSH terms
Substances
Grants and funding
- 944227/American Heart Association
- R01 HL167905/HL/NHLBI NIH HHS/United States
- UI/BD/151028/2021/Foundation for Science and Technology
- R01 AR073822/AR/NIAMS NIH HHS/United States
- AR074234;AR077132;HL115141;HL148207;HL148355;HL153356;HL167905;HL171239/Foundation for the National Institutes of Health
- R01 HL148207/HL/NHLBI NIH HHS/United States
- AY2022/2023/Fulbright Portugal
- NRF-2021R1A6A3A14039720/Ministry of Education
- R01 HL171239/HL/NHLBI NIH HHS/United States
- RG-22-135-39/Deanship of Scientific Research, Prince Sattam bin Abdulaziz University
- R01 HL153356/HL/NHLBI NIH HHS/United States
- R01 AR074234/AR/NIAMS NIH HHS/United States
- R01 HL148355/HL/NHLBI NIH HHS/United States
- R01 HL115141/HL/NHLBI NIH HHS/United States
- R01 AR077132/AR/NIAMS NIH HHS/United States
- HI22C2201/Korea Health Industry Development Institute/Republic of Korea
LinkOut - more resources
Full Text Sources
